tiprankstipranks
Lexicon Pharmaceuticals (LXRX)
NASDAQ:LXRX
US Market
LXRX
Lexicon Pharmaceuticals
RESEARCH TOOLSreports

Lexicon Pharmaceuticals (LXRX) Income Statement

1,789 Followers

Lexicon Pharmaceuticals Income Statement

Last quarter (Q4 2025), Lexicon Pharmaceuticals's total revenue was $5.49M, a decrease of -79.31% from the same quarter last year. In Q4, Lexicon Pharmaceuticals's net income was $-15.53M. See Lexicon Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 49.80M$ 31.08M$ 1.20M$ 139.00K$ 298.00K
Gross Profit
$ 49.53M$ 30.46M$ -57.77M$ -52.38M$ -54.75M
Operating Expenses
$ 98.44M$ 227.58M$ 113.98M$ 48.38M$ 32.34M
Depreciation and Amortization
$ 621.00K$ 534.00K$ 554.00K$ 427.00K$ 292.00K
EBITDA
$ -48.29M$ -184.29M$ -169.76M$ -100.03M$ -86.80M
Operating Income
$ -48.91M$ -197.12M$ -171.75M$ -100.76M$ -87.09M
Other Income/Expenses
$ -1.43M$ -3.29M$ -5.37M$ -1.18M$ -668.00K
Pretax Income
$ -50.34M$ -200.40M$ -177.12M$ -101.94M$ -87.76M
Net Income
$ -50.34M$ -200.40M$ -177.12M$ -101.94M$ -87.76M
Per Share Metrics
Basic EPS
$ -0.14$ -0.63$ -0.80$ -0.62$ -0.61
Diluted EPS
$ -0.14$ -0.63$ -0.80$ -0.62$ -0.61
Weighted Average Shares Outstanding
 363.05M 320.03M 221.13M 165.73M 145.65M
Weighted Average Shares Outstanding (Diluted)
 363.05M 320.03M 221.13M 165.73M 145.65M
Currency in USD

Lexicon Pharmaceuticals Earnings and Revenue History